LCTX:NYSEAMERICAN
Lineage Cell Therapeutics Inc
$0.94
arrow_upward
+1.64%(+0.015) 1D
Oct 6, 10:32:44 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LCTX...
Open
$0.94
High
$0.96
Low
$0.93
Mkt. cap
238.47M
Avg. vol.
1.34M
Volume
146.43K
52-wk high
$2.09
52-wk low
$0.88
EPS
-$0.14
Beta
1.60
Shares outstanding
252.91M
No. of employees
75
Open
$0.94
High
$0.96
Low
$0.93
Mkt. cap
238.47M
Avg. vol.
1.34M
Volume
146.43K
52-wk high
$2.09
52-wk low
$0.88
EPS
-$0.14
Beta
1.60
Shares outstanding
252.91M
No. of employees
75
News stories
From web sources and news partners
BigGo Finance
·
29 minutes ago
Triple Pressure Mounts: Veteran Investor Warns S&P 500 Could Pull Back 15%
TradingView
·
54 minutes ago
The Dow Jones Index Opens 0.35% Higher
Quartz
·
31 minutes ago
S&P 500 hits record high as oil prices and yields fall
Yahoo Finance
·
24 minutes ago
The 3 tech stocks accounting for over 20% of the S&P 500
Profile
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
About Lineage Cell Therapeutics Inc